|
Pronunciation |
|
(feks
oh FEN a deen & soo doe e
FED rin) |
|
|
U.S. Brand
Names |
|
Allegra-D™ |
|
|
Generic
Available |
|
No |
|
|
Pharmacological Index |
|
Antihistamine/Decongestant Combination |
|
|
Use |
|
Relief of symptoms associated with seasonal allergic rhinitis in adults and
children 12 years of age and older. Symptoms treated effectively include
sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes,
and nasal congestion. |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Usual Dosage |
|
Oral: Adults: One tablet twice daily for adults and children 12 years of age
and older. It is recommended that the administration with food should be
avoided. A dose of one tablet once daily is recommended as the starting dose in
patients with decreased renal function. |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
Pseudoephedrine component: Use with caution since pseudoephedrine is a
sympathomimetic amine which could interact with epinephrine to cause a pressor
response |
|
|
Dental Health:
Effects on Dental Treatment |
|
Pseudoephedrine component: Up to 10% of patients could experience
tachycardia, palpitations, and dry mouth; use vasoconstrictor with
caution |
|
|
Patient
Information |
|
Patients should be instructed to take tablets only as prescribed. Do not
exceed the recommended dose. If nervousness, dizziness, or sleeplessness occur,
discontinue use and consult the physician. Patients should also be advised
against the concurrent use of the tablets with over-the-counter antihistamines
and decongestants. The product should not be used by patients who are
hypersensitive to it or to any of its ingredients. Due to its pseudoephedrine
component, this product should not be used by patients with narrow-angle
glaucoma, urinary retention, or by patients receiving a monoamine oxidase (MAO)
inhibitor or within 14 days of stopping use of MAO inhibitor. It also should not
be used by patients with severe hypertension or severe coronary artery disease.
Patients should be told that this product should be used in pregnancy or
lactation only if the potential benefit justifies the potential risk to the
fetus or nursing infant. Patients should be cautioned not to break or chew the
tablet. Patients should be directed to swallow the tablet whole. Patients should
be instructed not to take the tablet with food. Patients should also be
instructed to store the medication in a tightly closed container in a cool, dry
place, away from children. |
|
|
Dosage Forms |
|
Tablet, extended release: Fexofenadine hydrochloride 60 mg and
pseudoephedrine hydrochloride 120
mg |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|